I Holland to host new series of technical webinars
Webinars will discuss tablet design and tool material selection, tool features and configuration and tooling maintenance and lifecycle management.
As this year marks I Holland’s 70th Anniversary in providing the highest quality tooling and technical support service to customers, the tabletting science experts will be sharing their tooling excellence with tablet manufacturers through a new series of webinars. These will discuss tablet design and tool material selection, tool features and configuration and tooling maintenance and lifecycle management.
The first webinar will take place on 12 May 2016 at 13.00 GMT+1 and is entitled ‘Improve production efficiency from tablet design to tool material specification.’ I Holland will show how efficiency in solid dose manufacturing can be improved at the earliest stages of the tablet design process, by utilising precise tooling specifications. They will explain how time saved at this stage can reduce a product’s time to market by eliminating downstream tabletting problems for the tablet producer.
Clare Taylor I Holland’s Marketing Manager states: "Webinars are a fantastic way of sharing invaluable knowledge with our industry peers on a global level. They are short, easy to follow educational pieces that are completely free for the audience to attend. The interactive question and answer session at the end of each webinar allows the audience to share their opinions and ideas on each topic being discussed."
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.